http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007537979-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-04 |
| filingDate | 2004-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007537979-A |
| titleOfInvention | Chemical compounds containing at least one other pharmaceutically active material in addition to tocopherol |
| abstract | The present invention relates to racemic, enantiomeric or diastereomeric forms of the general formula I [Chemical 1] [Wherein R represents the invariant portion of the pharmaceutically active material molecule to be changed, B represents the spacer, and Toc is the formula (Where R ′, R ″ and R ′ ″ correspond to H or methyl) and tocopherol, and A represents C═X, SO m , X or CH 2 , where X is O, S Or NR 1 (when n ≧ 1) or S or NR 1 (when n = 0), and B means the group X—R 2 —Y, where Y is C = X, SO m or C (XR 3 ) R 4 and n corresponds to 0 to 6, preferably 0, 1, 2 or 3 and m represents 1 or 2, R 1 Are linked through H, C 1 to C 10 -alkyl, preferably C 1 to C 6 -alkyl, or aryl or Het, or C 1 to C 6 -spacer, preferably C 1 to C 3 -spacer represents aryl or Het groups are, and R 2 is an alkylene, arylene Or Het spacers not only be selected from the group consisting of, where the latter is linked directly or through a group A or group X o -A-X p each other, wherein, o and p are 0, Corresponding to 1 or 2, and the latter may be the same or different and R 3 and R 4 are H, C 1 to C 10 -alkyl, preferably C 1 -C 6 -alkyl, or aryl or Het, Or represents an aryl or Het group attached through a C 1 to C 6 -spacer, preferably a C 1 to C 3 -spacer] It relates to a chemical compound represented by |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9169187-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9670121-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5768712-B2 |
| priorityDate | 2003-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 193.